TABLE 3.

Comparison of surveillance interval and tumour stage determined using the Barcelona Clinic Liver Cancer (BCLC) staging system

Surveillance	Total, n	BCLC stage			Missed
		0	A	B to D
Regular*	109	36 (33)	51 (47)	13 (12)	9 (8)
Irregular†	38	8 (21)	18 (47)	9 (24)	3 (8)
First	54	14 (26)	27 (50)	11 (20)	2 (4)

Data presented as n (%) unless otherwise indicated.

^*Frequency of surveillance ≤12 months;

^†Frequency of surveillance >12 months